期刊文献+

MiR-340经组织型纤溶酶原激活剂调控施万细胞的纤溶能力

MicroRNA-340 regulates the fibrinolytic capacity of Schwann cells by targeting tPA
在线阅读 下载PDF
导出
摘要 目的:探讨microRNA-340(miR-340)对施万细胞纤溶能力的调控作用及作用的靶基因。方法:采用溶圈实验来检测miR-340对施万细胞纤溶能力的影响,用荧光素酶双报告基因系统确定miR-340与组织型纤溶酶原激活剂的靶向关系,用实时定量聚合酶链反应检测坐骨神经夹伤后组织型纤溶酶原激活剂mRNA和miR-340的表达变化。结果:miR-340能够抑制施万细胞的纤溶能力,并直接靶向作用于组织型纤溶酶原激活剂的3'UTR,坐骨神经夹伤后组织型纤溶酶原激活剂mRNA与miR-340的表达呈负相关性。结论:miR-340通过直接靶向组织型纤溶酶原激活剂的3'UTR,从而下调靶基因组织型纤溶酶原激活剂的表达抑制施万细胞的纤溶能力。 Objective: To investigate the regulatory role of miR-340 on the fibrinolytic capacity of Schwann cells and the target gene of miR-340. Methods: Fibrinolysis assay was used to examine the influence of miR-340 on the fibri-nolytic capacity of Schwann cells. Dual luciferase assay system was used to determine whether miR-340 targets the 3′UTR of tPA. Real-time PCR was used to examine the expression of tPA mRNA and miR-340 follwoing sciatic nerve injury. Results: miR-340 inhibits the fibrinolytic activity of Schwann cells and targets the 3′UTR of tPA directly. The expression of tPA mRNA was negatively correlated with that of miR-340. Conclusion: This study reveals that miR-340 inhibits the fibrinolytic activity of Schwann cells by targeting tPA.
出处 《交通医学》 2015年第1期1-3,共3页 Medical Journal of Communications
基金 国家863计划项目(2012AA020502) 国家自然科学基金重点项目(81130080) 国家自然科学基金青年基金(31300879) 江苏省自然科学基金青年基金(BK2012230)
关键词 MicroRNA-340 组织型纤溶酶原激活剂 坐骨神经 施万细胞 纤溶能力 实时定量聚合酶链反应 大鼠 MicroRNA -340 tissue plasminogen activator sciatic nerve schwann cells fibrinolysis real time poly-merase chain reaction rat
  • 相关文献

参考文献10

  • 1Jinek M,D oudna JA.A three-dimensional view of the molecular machinery of RNA interference[J].Nature,2009,457(7228):405-412.
  • 2Vasudevan S,Tong Y,Steitz JA.Switching from repression to activation:micro RNAs can up-regulate translation[J].Science,2007,318(5858):1931-1934.
  • 3Krol J,Loedige I,Filipowicz W.The widespread regulation of micro RNA biogenesis,function and decay[J].Nat Rev Genet,2010,11(9):597-610.
  • 4Chang YM,Shih YT,Chen YS,et al.Schwann cell migration induced by earthworm extract via activation of PAs and MMP2/9 mediated through ERK1/2 and p38[J].EvidenceBased Complementary and Alternative Medicine,2011 2011;2011:395458.doi:10.1093/ecam/nep131.Epub 2011 Jan 4.
  • 5García-Rocha M,Avila J,Armas-Portela R.Tissue-type plasminogen activator(t PA)is the main plasminogen activator associated with isolated rat nerve growth cones[J].Neurosci Lett,1994,180(2):123-126.
  • 6Mack TG,Reiner M,Beirowski B,et al.Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene[J].Nat Neurosci,2001,4(12):1199-1206.
  • 7Lee SK,Wolfe SW.Peripheral nerve injury and repair[J].J Am Acad Orthop Surg,2000,8(4):243-252.
  • 8Siconolfi LB,Seeds NW.Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush[J].Journal of Neuroscience,2001,21(12):4336-4347.
  • 9Strong AM,Setaluri V,Spiegelman VS.micro RNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma[J].Arch Biochem Biophys,2014,563(SI):118-124.
  • 10Siconolfi LB,Seeds NW.Mice lacking t PA,u PA,or plasminogen genes showed delayed functional recovery after sciatic nerve crush[J].J Neurosci,2001,21(12):4348-4355.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部